ICICI Prudential AMC IPO | The maiden public issue from the ICICI Group company will open for the public during December 12-16, with price band of Rs 2,061-2,165 per share.
Geojit Financial Services, has come out with its report on Nephrocare Health Services Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 10, 2025.
Anand Rathi, has come out with its report on ICICI Prudential AMC Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 09, 2025.
All these three companies closed their public issues today, December 10 and will finalise their IPO share allotment by December 11. Their shares will be available for trading on the BSE SME effective December 15.
Anand Rathi, has come out with its report on Park Medi World Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 09, 2025.
Anand Rathi, has come out with its report on Nephrocare Health Services Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 09, 2025.
Park Medi World IPO | The Rs 920-crore initial public offering will open during December 10-12, with price band of Rs 154-162 per share.
The Nephrocare Health Services IPO is a combination of fresh issuance of shares worth Rs 353.4 crore, and an offer-for-sale of 1.12 crore shares by existing shareholders.
Deven Choksey, has come out with its report on Wakefit Innovations Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 08, 2025.
Nephrocare Health Services IPO | The company approached capital markets to raise Rs 871 crore via initial public offering (IPO) comprising fresh issuance of shares worth Rs 353.4 crore.
Bengaluru-based home & furnishings company Wakefit Innovations, and pharmaceutical firm Corona Remedies will be the first amongst them in the mainboard segment, opening IPOs on December 8 with price band of Rs 185-195 per share and Rs 1,008-1,062 per share, respectively.
Wakefit Innovations IPO | The company hit Dalal Street with its Rs 1,289-crore initial public offering.
Corona Remedies IPO | The company has finalised allocation of 18.34 lakh shares to anchor investors at the upper price band.
Geojit Financial Services, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 03, 2025.
Geojit Financial Services, has come out with its report on Meesho Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 03, 2025.
Ajcon Global, has come out with its report on Meesho Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 03, 2025.
Ajcon Global, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
Deven Choksey, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
Anand Rathi, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
Anand Rathi, has come out with its report on Meesho Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
Aequs IPO | The initial share sale will open for subscription on December 3 and close on December 5.
More than 60 institutional investors participated in the anchor round.
The anchor book attracted 10 institutional investors, with domestic mutual funds accounting for 77.78 percent of the total allocation. These domestic funds invested through seven schemes across three fund houses.
Other investors including GIC, ADIA, Fidelity International, Fidelity Management & Research, Baillie Gifford, Wellington and Goldman Sachs Asset Management also bid to participate in the anchor round, a source told Moneycontrol.
That decision triggered a pushback from other large funds, the people said, asking not to be identified as the information is private. Meesho is set to open its anchor book — a portion of shares reserved for institutional investors — on Tuesday ahead of its initial public offering that launches on Wednesday